242 related articles for article (PubMed ID: 8609905)
1. Distinct receptor domains determine subtype-specific coupling and desensitization phenotypes for human beta1- and beta2-adrenergic receptors.
Rousseau G; Nantel F; Bouvier M
Mol Pharmacol; 1996 Apr; 49(4):752-60. PubMed ID: 8609905
[TBL] [Abstract][Full Text] [Related]
2. Cellular characterization of the pharmacological selectivity and tachyphylactic properties of denopamine for the human beta adrenergic receptors.
Suzuki T; Nantel F; Bonin H; Valiquette M; Bouvier M
J Pharmacol Exp Ther; 1993 Nov; 267(2):785-90. PubMed ID: 7902433
[TBL] [Abstract][Full Text] [Related]
3. Role of specific protein kinase C isoforms in modulation of beta1- and beta2-adrenergic receptors.
Guimond J; Mamarbachi AM; Allen BG; Rindt H; Hébert TE
Cell Signal; 2005 Jan; 17(1):49-58. PubMed ID: 15451024
[TBL] [Abstract][Full Text] [Related]
4. The human beta 3-adrenergic receptor is resistant to short term agonist-promoted desensitization.
Nantel F; Bonin H; Emorine LJ; Zilberfarb V; Strosberg AD; Bouvier M; Marullo S
Mol Pharmacol; 1993 Apr; 43(4):548-55. PubMed ID: 8386307
[TBL] [Abstract][Full Text] [Related]
5. Expression of a human cDNA encoding the beta 2-adrenergic receptor in Chinese hamster fibroblasts (CHW): functionality and regulation of the expressed receptors.
Bouvier M; Hnatowich M; Collins S; Kobilka BK; Deblasi A; Lefkowitz RJ; Caron MG
Mol Pharmacol; 1988 Feb; 33(2):133-9. PubMed ID: 2828911
[TBL] [Abstract][Full Text] [Related]
6. Functional receptor coupling to Gi is a mechanism of agonist-promoted desensitization of the beta2-adrenergic receptor.
Tepe NM; Liggett SB
J Recept Signal Transduct Res; 2000 Jan; 20(1):75-85. PubMed ID: 10711498
[TBL] [Abstract][Full Text] [Related]
7. Agonist interactions with chimeric and mutant beta1- and beta3-adrenergic receptors: involvement of the seventh transmembrane region in conferring subtype specificity.
Granneman JG; Lahners KN; Zhai Y
Mol Pharmacol; 1998 May; 53(5):856-61. PubMed ID: 9584211
[TBL] [Abstract][Full Text] [Related]
8. Distinct interactions of human beta1- and beta2-adrenoceptors with isoproterenol, epinephrine, norepinephrine, and dopamine.
Weitl N; Seifert R
J Pharmacol Exp Ther; 2008 Dec; 327(3):760-9. PubMed ID: 18772317
[TBL] [Abstract][Full Text] [Related]
9. Regulation of cyclic adenosine monophosphate release by selective β2-adrenergic receptor stimulation in human terminal failing myocardium before and after ventricular assist device support.
Kassner A; Toischer K; Bohms B; Kolkhof P; Abraham G; Hasenfuβ G; Morshuis M; Schulte Eistrup S; El-Banayosy A; Gummert J; Milting H
J Heart Lung Transplant; 2012 Oct; 31(10):1127-35. PubMed ID: 22975104
[TBL] [Abstract][Full Text] [Related]
10. Divergent agonist selectivity in activating β1- and β2-adrenoceptors for G-protein and arrestin coupling.
Casella I; Ambrosio C; Grò MC; Molinari P; Costa T
Biochem J; 2011 Aug; 438(1):191-202. PubMed ID: 21561432
[TBL] [Abstract][Full Text] [Related]
11. Stable activation and desensitization of beta 2-adrenergic receptor stimulation of adenylyl cyclase by salmeterol: evidence for quasi-irreversible binding to an exosite.
Clark RB; Allal C; Friedman J; Johnson M; Barber R
Mol Pharmacol; 1996 Jan; 49(1):182-9. PubMed ID: 8569705
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological characterization of putative beta1-beta2-adrenergic receptor heterodimers.
Lavoie C; Hébert TE
Can J Physiol Pharmacol; 2003 Feb; 81(2):186-95. PubMed ID: 12710533
[TBL] [Abstract][Full Text] [Related]
13. Enhanced G(i) signaling selectively negates beta2-adrenergic receptor (AR)--but not beta1-AR-mediated positive inotropic effect in myocytes from failing rat hearts.
Xiao RP; Zhang SJ; Chakir K; Avdonin P; Zhu W; Bond RA; Balke CW; Lakatta EG; Cheng H
Circulation; 2003 Sep; 108(13):1633-9. PubMed ID: 12975249
[TBL] [Abstract][Full Text] [Related]
14. Heterodimerization of beta1- and beta2-adrenergic receptor subtypes optimizes beta-adrenergic modulation of cardiac contractility.
Zhu WZ; Chakir K; Zhang S; Yang D; Lavoie C; Bouvier M; Hébert TE; Lakatta EG; Cheng H; Xiao RP
Circ Res; 2005 Aug; 97(3):244-51. PubMed ID: 16002745
[TBL] [Abstract][Full Text] [Related]
15. Functional characterization of the beta-adrenergic receptor subtypes expressed by CA1 pyramidal cells in the rat hippocampus.
Hillman KL; Doze VA; Porter JE
J Pharmacol Exp Ther; 2005 Aug; 314(2):561-7. PubMed ID: 15908513
[TBL] [Abstract][Full Text] [Related]
16. Functional alpha 2-adrenergic receptor-Gs coupling undergoes agonist-promoted desensitization in a subtype-selective manner.
Eason MG; Liggett SB
Biochem Biophys Res Commun; 1993 May; 193(1):318-23. PubMed ID: 8099284
[TBL] [Abstract][Full Text] [Related]
17. Ontogeny of regulatory mechanisms for beta-adrenoceptor control of rat cardiac adenylyl cyclase: targeting of G-proteins and the cyclase catalytic subunit.
Zeiders JL; Seidler FJ; Slotkin TA
J Mol Cell Cardiol; 1997 Feb; 29(2):603-15. PubMed ID: 9140819
[TBL] [Abstract][Full Text] [Related]
18. Beta 2-adrenergic receptor mutants reveal structural requirements for the desensitization observed with long-term epinephrine treatment.
Proll MA; Clark RB; Butcher RW
Mol Pharmacol; 1993 Sep; 44(3):569-74. PubMed ID: 8396717
[TBL] [Abstract][Full Text] [Related]
19. Mutagenesis within helix 6 of the human beta1-adrenergic receptor identifies Lysine324 as a residue involved in imparting the high-affinity binding state of agonists.
Zeitoun O; Santos NM; Gardner LA; White SW; Bahouth SW
Mol Pharmacol; 2006 Sep; 70(3):838-50. PubMed ID: 16760361
[TBL] [Abstract][Full Text] [Related]
20. Agonist-induced modulation of inverse agonist efficacy at the beta 2-adrenergic receptor.
Chidiac P; Nouet S; Bouvier M
Mol Pharmacol; 1996 Sep; 50(3):662-9. PubMed ID: 8794908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
